Conformis announced that independent, retrospective review of hospital data suggest that iTotal® knee replacement technology is more cost-effective than leading traditional, off-the-shelf implants.
The retrospective review was performed at a single medical institution between 2016 and 2019 using a financial database and electronic health records. Patient demographics, total direct costs, length of stay (LOS) and opioid use were all investigated.
The review comprised three groups:
Primary group – patient-specific implant (Conformis iTotal)
Comparison group – traditional implant (Zimmer Persona®)
Control group – traditional implant (Stryker Triathlon®)
Results indicate:
Mean Length of Stay Analysis:
1.35 days for Conformis iTotal patients
1.99 days for Zimmer Persona patients
1.83 for Stryker Triathlon patients
Total Direct Costs Analysis:
$9,341 for Conformis iTotal® patients (savings of $1,006 to $1,263 per patient)
$10,347 for Zimmer Persona® patients
$10,604 for Stryker Triathlon® patients
The study concludes that total direct costs for hospital admissions appear to be more cost-effective with Conformis iTotal, and variables such as operative time and length of stay also appear to favor a patient-specific implant over traditional, off-the-shelf implants.
Conformis announced that independent, retrospective review of hospital data suggest that iTotal® knee replacement technology is more cost-effective than leading traditional, off-the-shelf implants.
The retrospective review was performed at a single medical institution between 2016 and 2019 using a financial database and electronic health...
Conformis announced that independent, retrospective review of hospital data suggest that iTotal® knee replacement technology is more cost-effective than leading traditional, off-the-shelf implants.
The retrospective review was performed at a single medical institution between 2016 and 2019 using a financial database and electronic health records. Patient demographics, total direct costs, length of stay (LOS) and opioid use were all investigated.
The review comprised three groups:
Primary group – patient-specific implant (Conformis iTotal)
Comparison group – traditional implant (Zimmer Persona®)
Control group – traditional implant (Stryker Triathlon®)
Results indicate:
Mean Length of Stay Analysis:
1.35 days for Conformis iTotal patients
1.99 days for Zimmer Persona patients
1.83 for Stryker Triathlon patients
Total Direct Costs Analysis:
$9,341 for Conformis iTotal® patients (savings of $1,006 to $1,263 per patient)
$10,347 for Zimmer Persona® patients
$10,604 for Stryker Triathlon® patients
The study concludes that total direct costs for hospital admissions appear to be more cost-effective with Conformis iTotal, and variables such as operative time and length of stay also appear to favor a patient-specific implant over traditional, off-the-shelf implants.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Copy to clipboard 
